Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Bloomberg: Sun plant banned by FDA had same issues faced by Ranbaxy

25.04.2014 / Fierce Pharma

Sun Pharmaceutical&#39;s $3.2 billion buyout offer for Ranbaxy Laboratories also came with a pledge to clean up the act of India&#39;s largest generic drugmaker, which has had four plants banned by the FDA. But Sun also recently had a plant nixed by the FDA, and <em>Bloomberg</em> learned it was for many of the same issues faced by Ranbaxy.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: